Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
David Kent, MD, MS
Covert Cerebrovascular Disease Detected by Artificial Intelligence (C2D2AI): Pilot Investigation for Pragmatic Neuroimaging Biomarkers for Future Stroke and Dementia Risk
A GuideStar-Rated Charity
© Copyright 2024. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).